Julia Bonavitacola

A simple, user-friendly decision-making model that used self-reported information was able to perform well in outpatient decision-making for patients with colorectal cancer (CRC).

Patients with colorectal liver metastases had local tumor progression when they had minimal ablative margin from intraprocedural contrast-enhanced computed tomography.

New therapies to treat EGFR-mutated non–small cell lung cancer (NSCLC) following EGFR tyrosine kinase inhibitors (TKIs) are needed to address EGFR TKI resistance after osimertinib.

Tumor location, tumor size, and T stage associated with patients with rectal cancer who have inferior mesenteric artery lymph node metastases.

A new study has found that prior authorizations for anti–vascular endothelial growth factor treatment led to a delay in patient care for most patients.

Test your knowledge of the July 2024 issue of AJMC with this quick quiz!

Mina Massaro-Giordano, MD, discusses how raising awareness about dry eye can help patients avoid worsening the condition.

The Shield blood test developed by Guardant has been approved by the FDA as a primary screening option for colorectal cancer, providing a more convenient method of screening.

Doug Fulling, MA, and Andrew Cournoyer of Precision AQ discussed what payers can contribute to discussions around drug pricing during clinical development.

Patients with unresectable stage III non–small cell lung cancer (NSCLC) who received atezolizumab before and after chemoradiation therapy (CRT) had both safe and effective results.

A late-breaking abstract focused on a head-to-head comparison between dolutegravir/lamivudine (DTG/3TC) and bictegravir/emtricitabine/tenofovir (BIC/FTC/TAF) in the treatment of HIV.

Patients diagnoesd with metabolic dysfunction–associated steatotic liver disease may have a higher risk of colorectal cancer (CRC) or colorectal adenoma.

Doug Fulling, MA, and Andrew Cournoyer, MBA, discuss how patients could benefit from payers learning more about a new drug by joining clinical trials earlier.

Andrew Cournoyer discusses how introducing payers into clinical trials earlier could help make the introduction of new technologies into the space more efficient and less time-consuming.

Jessilin Quint, OD, MBA, FAAO, and Rebecca Petris discussed the different presentations of dry eye and how patients can address their symptoms with their doctors.

The Society for Pediatric Dermatology (SPD) Annual Meeting focused on different aspects of pediatric dermatology, including topical treatments, technology, and misinformation.

Introducing payers into clinical trials earlier could help to shape the value of a drug, according to Andrew Cournoyer of Precision AQ.

The combination of a high proportion of new diagnoses of HIV with the high prevalence of HIV indicate that an epidemic of HIV could be growing.

Overall and site-specific colorectal cancer (CRC) had a negative association with the usage of aspirin.

Experts in dermatology presented ways in which biologic therapies can be given and the duration of treatment when used in pediatric patients with skin conditions.

Mina Massaro-Giordano, MD, discussed the ways that dry eye can affect patients with the condition, as well as what symptoms can fly under the radar.

Posters presented at the Society for Pediatric Dermatology Annual Meeting found that pediatric deroofing can lead to patient satisfaction later in life.

Updates in nonsteroidal topical therapies were presented during a session at the Society for Pediatric Dermatology Annual Meeting.

A presentation at the Society for Pediatric Dermatology Annual Conference discussed how to use generative artificial intelligence (AI) to improve processes while working in the dermatology space.

The Society for Pediatric Dermatology (SPD) Annual Meeting featured a new debates segment where experts in the field discussed preferred strategies for the treatment of pediatric skin conditions.

Doug Fulling, MA, discussed how introducing payers into clinical research earlier could help manufacturers, payers, and patients.

Community support and molecular epidemiological approaches could help HIV prevention in Australia.

Twice-daily application of 1.5% ruxolitinib cream was found to be effective in children and adolescents with atopic dermatitis and vitiligo.

Jessilin Quint, OD, MBA, FAAO, from Smart Eye Care, and Rebecca Petris, co-founder of the Dry Eye Foundation, spoke about their biggest takeaways from a recent dry eye survey conducted by The Harris Poll on behalf of Bausch + Lomb.

A nomogram model that included log odd of positive lymph node was effective in predicting prognosis of early-onset colorectal cancer (EOCRC).